EIRGEN
Live / Registered — Registered (as of 26 Sept 2023)
What this means for you
Registered since 26 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97383276
- Registration number
- 7172805
- Mark type
- Stylized text
- Filed
- 26 Apr 2022
- Published for opposition
- 11 Jul 2023
- Registered
- 26 Sept 2023
- Attorney of record
- Sean P. McMahon
Goods and services
- Class 001 — Chemicals: Chemicals used in industry, science and photography; chemical substances for preserving foodstuffs; adhesives used in industry; biological preparations for use in biotechnology other than for medical use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; sanitary preparations for medical use; prescription pharmaceutical and biotechnological preparations for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; biological preparations for medical purposes, namely, for use in biotechnology for the treatment of cancer, infectious diseases, metabolic diseases and disorders; chemical preparations and reagents for use in biotechnology for medical and veterinary use, namely, renal diseases and disorders, cognitive and neurological disorders, vitamin D insufficiencies, cancer and infectious diseases; injectable solutions for medical purposes, namely, injectable pharmaceuticals for cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders; dietetic foods, namely, pasta, crackers, and bread, food supplements, infusions, drinks and beverages all adapted for medical use; all purpose disinfectants, oral disinfectants for medical and hygienic purposes, disinfectants for hygienic and sanitary purposes, disinfectants for medical instruments; syrups for pharmaceutical purposes, namely, cough syrups; vaccines; syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use; pre-filled disposable syringes and hypodermic syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use
- Class 042 — Scientific and technological services: The provision of information on the subject of research and development, drug development and product evaluation all in the field of pharmaceuticals and biotechnology; scientific and industrial research relating to pharmaceuticals and biotechnology
Owner
- EirGen Pharma Limited, Waterford, IE
- EirGen Pharma Limited, Waterford, IE
- EirGen Pharma Limited, Waterford, IE
Prosecution history
- 26 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jul 2023 — PUBLISHED FOR OPPOSITION
- 21 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Jun 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 02 Jun 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 30 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 May 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 May 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 13 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Feb 2023 — NON-FINAL ACTION E-MAILED